Abrdn Life Sciences Investors
US ˙ NYSE ˙ US87911K1007

SecurityHQL / Abrdn Life Sciences Investors
InstitutionPrivate Advisor Group, LLC
Latest Disclosed Ownership76,980 shares
Latest Disclosed Value $ 1,252,458
Private Advisor Group, LLC reports 19.86% increase in ownership of HQL / Abrdn Life Sciences Investors

On April 24, 2026 - Private Advisor Group, LLC filed a 13F-HR form disclosing ownership of 76,980 shares of Abrdn Life Sciences Investors (US:HQL) valued at $1,252,465 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 64,227 shares of Abrdn Life Sciences Investors. This represents a change in shares of 19.86% during the quarter. The current value of the position is $1,302,502 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 76,980 12,753 19.86 1,252 16.25 0.0056
2026-02-17 2025-12-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 64,227 539 0.85 1,078 9.12 0.0049
2025-11-13 2025-09-30 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 63,688 12,356 24.07 988 50.23 0.0049
2025-08-11 2025-06-30 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 51,332 28,257 122.46 658 125.00 0.0035
2025-05-05 2025-03-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 23,075 1,097 4.99 293 1.39 0.0018
2025-02-03 2024-12-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 21,978 -4,351 -16.53 288 -27.46 0.0016
2024-10-22 2024-09-30 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 26,329 -924 -3.39 397 2.85 0.0025
2024-08-05 2024-06-30 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 27,253 -4,510 -14.20 386 -10.65 0.0026
2024-04-30 2024-03-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 31,763 -2,411 -7.06 433 -6.09 0.0031
2024-02-06 2023-12-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 34,174 -872 -2.49 460 5.75 0.0036
2023-11-03 2023-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 35,046 15,459 78.92 435 64.15 0.0039
2023-08-10 2023-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 19,587 0 0.00 265 -2.57 0.0023
2023-05-10 2023-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 19,587 0 0.00 273 0.0026
2023-01-18 2022-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 19,587 -4,942 -20.15 0 -100.00 0.0000
2022-10-14 2022-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 24,529 3,921 19.03 335 14.33 0.0039
2022-07-13 2022-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 20,608 498 2.48 293 -12.01 0.0026
2022-05-12 2022-03-31 13F/A-1 TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 20,110 -752 -3.60 333 -16.96 0.0026
2022-05-10 2022-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 20,862 0 401 0.0030
2022-02-10 2021-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 20,862 -3,260 -13.51 401 -20.12 0.0030
2021-10-14 2021-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 24,122 24,122 502 0.0032
2020-02-07 2019-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 0 -84,142 -100.00 0 -100.00
2019-11-13 2019-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 84,142 39,581 88.82 1,359 80.96 0.0211
2019-08-14 2019-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 44,561 3,185 7.70 751 5.92 0.0136
2019-05-13 2019-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 41,376 2,322 5.95 709 20.17 0.0140
2019-02-08 2018-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 39,054 4,201 12.05 590 -17.13 0.0142
2018-11-01 2018-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 34,853 3,913 12.65 712 22.55 0.0146
2018-08-09 2018-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 30,940 9,173 42.14 581 39.00 0.0095
2018-05-09 2018-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 21,767 21,767 418 0.0164
2017-02-09 2016-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 0 -15,653 -100.00 0 -100.00
2016-11-10 2016-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 15,653 624 4.15 290 8.21 0.0118
2016-08-09 2016-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 15,029 -806 -5.09 268 -5.63 0.0108
2016-05-13 2016-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 15,835 1,556 10.90 284 -15.98 0.0137
2016-02-09 2015-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 14,279 535 3.89 338 9.39 0.0162
2015-11-13 2015-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 13,744 6,492 89.52 309 50.73 0.0170
2015-08-13 2015-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 7,252 7,252 205 0.0097
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.